Literature DB >> 9572237

Limb girdle muscular dystrophy: a pathological and immunohistochemical reevaluation.

A J van der Kooi1, H B Ginjaar, H F Busch, J H Wokke, P G Barth, M de Visser.   

Abstract

Ninety-seven muscle biopsies from 81 limb girdle muscular dystrophy (LGMD) patients [32 autosomal recessive (AR), 15 autosomal dominant (AD), 34 sporadic] were morphologically reevaluated. Sarcoglycan analysis was done in 37 available muscle biopsies of AR and sporadic patients. Chi-square tests were used to analyze the relation between abnormalities in AR/sporadic versus AD cases. Eighty percent of the muscle biopsies showed a predominantly dystrophic pattern, 20% showed myopathic changes, and 17% of these also had neurogenic changes. Muscle histology was not significantly different between AR/sporadic and AD LGMD; however, the observed abnormalities were more pronounced in the AR/sporadic group. Collections of inflammatory cells were observed in 25% and 10% of the AR/sporadic and AD group, respectively. Sarcoglycanopathy was diagnosed in 25% of the AR and sporadic patients of the 37 families tested. We conclude that the histological picture of AR/sporadic and AD LGMD is essentially the same, and sarcoglycanopathy constitutes an important part of the AR/sporadic patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9572237     DOI: 10.1002/(sici)1097-4598(199805)21:5<584::aid-mus4>3.0.co;2-4

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  1 in total

1.  New Insights into the Neuromyogenic Spectrum of a Gain of Function Mutation in SPTLC1.

Authors:  Heike Kölbel; Florian Kraft; Andreas Hentschel; Artur Czech; Andrea Gangfuss; Payam Mohassel; Chi Nguyen; Werner Stenzel; Ulrike Schara-Schmidt; Corinna Preuße; Andreas Roos
Journal:  Genes (Basel)       Date:  2022-05-17       Impact factor: 4.141

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.